Q2 2026 Holdings
Filed 2026-08-14 | 39 holdings | $746.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $46.9M | 39,086 | 6.3% |
| Pfizer Inc(PFE) | COM | 717081103 | $42.7M | 1,771,743 | 5.7% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $42.0M | 236,709 | 5.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $39.0M | 682,005 | 5.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $35.4M | 433,699 | 4.7% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $31.1M | 1,459,380 | 4.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $30.0M | 281,838 | 4.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $27.3M | 317,426 | 3.7% |
| Insulet Corp(PODD) | COM | 45784P101 | $26.9M | 176,932 | 3.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $26.0M | 51,934 | 3.5% |
| Abbott Laboratories(ABT) | COM | 002824100 | $25.9M | 285,778 | 3.5% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $25.3M | 94,843 | 3.4% |
| Solventum Corp(SOLV) | COM SHS | 83444M101 | $24.4M | 316,454 | 3.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $23.7M | 303,301 | 3.2% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $21.3M | 864,080 | 2.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $20.3M | 546,848 | 2.7% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $19.1M | 726,108 | 2.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $15.5M | 82,827 | 2.1% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $15.5M | 105,700 | 2.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $15.2M | 393,441 | 2.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $14.7M | 132,662 | 2.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $14.6M | 1,490,286 | 2.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $13.9M | 3,525,338 | 1.9% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $12.0M | 376,870 | 1.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $11.6M | 924,758 | 1.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $11.3M | 1,047,690 | 1.5% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $11.2M | 3,670,135 | 1.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $11.0M | 139,637 | 1.5% |
| Enovis Corporation(ENOV) | COM | 194014502 | $11.0M | 531,945 | 1.5% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $10.5M | 793,145 | 1.4% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $10.2M | 80,118 | 1.4% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $10.1M | 391,866 | 1.3% |
| Glaukos Corp(GKOS) | COM | 377322102 | $9.3M | 66,519 | 1.2% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $9.2M | 322,126 | 1.2% |
| Pacs Group Inc(PACS) | COM SHS | 69380Q107 | $9.2M | 215,675 | 1.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $9.0M | 239,440 | 1.2% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $8.8M | 107,373 | 1.2% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.1M | 1,674,999 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $2.4M | 7,558,756 | 0.3% |